A confirmatory dose-ranging study of riluzole in ALS

Lucette Lacomblez(Sorbonne Université), Vincent Meininger(Sorbonne Université), Gilbert Bensimon(Pitié-Salpêtrière Hospital), Philippe Guillet(Unknown), P. Nigel Leigh, Sylvain Durrleman, Larry K. Powe, Jean-Christophe Delumeau

Neurology

December 1, 1996

10.1212/wnl.47.6_suppl_4.242s

Cited by 198

Related Papers

A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis

|New England Journal of Medicine|1994|2.2k

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

|Nature Genetics|2008|1.5k

Dose-ranging study of riluzole in amyotrophic lateral sclerosis

|The Lancet|1996|1.3k

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

|Nature Genetics|2016|633

Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis

|Nature|2012|599